previous compound ID: 2516 next compound
InChIKey: WUILNKCFCLNXOK-CFBAGHHKSA-N
SMILES: CC(=CCC/C(=C/CC/C(=C/CSC1=CC=CC=C1C(=O)O)/C)/C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "J Goepp" "R Robert" "E Matthes" "SD Macknight" "D Rotin" "JW Hanrahan" "B Kus" "J Liao" "DY Thomas"

chemical graph of compound 2516





CID is 5469318
synonyms found at PubChem are:
Salirasib, 162520-00-5, Farnesylthiosalicylic acid, S-Farnesylthiosalicylic acid, UNII-MZH0OM550M, FTS, Farnesylthiosalicyclic acid, MZH0OM550M, CHEMBL23293, 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid, 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic Acid, 2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoic acid, 2-(((2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl)sulfanyl)benzoic acid, Benzoic acid, 2-(((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl)thio)-, Salirasib [USAN], Salirasib [USAN:INN], S-trans, FTS, Thyreos, Farnesylthiosalicylate, S-trans,trans-farnesylthiosalicylic acid, Ras antagonists, Thyreos, Salirasib (INN/USAN), Lopac-F-8175, D00KTV, D05YQY, AC1NV5Y3, Lopac0_000517, MLS006010835, Trans-farnesylthiosalicylicacid, GTPL6281, FTS (oral, cancer), Concordia, Salirasib, >=98% (HPLC), Th-101, MolPort-003-847-356, WUILNKCFCLNXOK-CFBAGHHKSA-N, KD032, BCP27978, EX-A1170, ONO-7056, Ras-inhibitors (cancer), Concordia, trans,trans-Farnesylthiobenzoic acid, ZINC1650377, FTS (oral, cancer), Concordia/Ono, 2030AH, BDBM50034278, IN2128, KD-032, NSC685986, s7684, AKOS024458453, CCG-204607, CS-0681, DB12681, NSC-685986, trans,trans Farnesyl Thiosalicylic Acid, NCGC00015448-01, NCGC00015448-02, NCGC00015448-03, NCGC00093912-01, NCGC00093912-02, AK186909, BC600693, HY-14754, SMR004701762, LS-186975, LS-187617, EU-0100517, D08995, F 8175, W-5109, Farnesylthiosalicylic acid, >98% (HPLC), solid, SR-01000075885, J-009946, SR-01000075885-1, Farnesylthiosalicyclic acid (oral, cancer), Concordia, 2-[(3,7,11-Trimethyl-2,6,10-dodecatrienyl)thio]benzoic acid, (E,E)-2-[(3,7,11-Trimethyl-2,6,10-dodecatrienyl)thio]benzoic Acid, 2-((2E,6E)-3,7,11-Trimethyl-dodeca-2,6,10-trienylsulfanyl)-benzoic acid, 166445-40-5